IMARC Group has recently released a new research study titled “United States Animal Health Market Report by Animal Type, Product Type, and Region, 2026-2034,” offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.
United States Animal Health Market Size, Growth, and Forecast (2026-2034)
The united states animal health market size reached USD 20.92 Billion in 2025 and is projected to reach USD 47.65 Billion by 2034, growing at a CAGR of 9.58% during 2026-2034. Rising pet ownership, growing livestock disease burden, and advancements in veterinary diagnostics and biologicals are the primary factors driving the united states animal health market.
Animal health encompasses the pharmaceuticals, biologicals, diagnostics, and medicated feed additives used to prevent, diagnose, and treat disease in both companion and commercial animals. It supports veterinary care across cattle, swine, poultry, and aquaculture operations as well as the growing base of household pets, spanning vaccines, antiparasitics, antibiotics, and point-of-care testing equipment.
The United States is witnessing rising humanization of pets alongside a persistent disease burden across commercial livestock operations, together creating sustained demand for both preventive and treatment-oriented animal health products. As pet owners increase spending on veterinary care and large-scale producers invest in herd health management, manufacturers and service providers are expanding their portfolios of pharmaceuticals, biologicals, and diagnostic solutions across the country.
Analyze the Global Fitness App Market — Download the IMARC Sample Report for Insights: https://www.imarcgroup.com/united-states-animal-health-market/requestsample
Key Trends Driving the United States Animal Health Market
• Rising pet ownership and companion animal healthcare spending: Growing pet ownership across the United States, combined with increasing humanization of pets, is driving higher per-pet healthcare spending. For instance, in 2025, Zoetis' Vetscan OptiCell was recognized as “Best New Companion Animal Product” by S&P Global Animal Health, underscoring the pace of innovation in companion animal diagnostics and the growing demand for advanced veterinary care.
• Growing livestock disease burden and herd health management: Rising incidence of diseases such as bovine respiratory disease, swine influenza, and avian influenza is increasing demand for vaccines, antibiotics, and biosecurity products. Large integrated production systems require comprehensive herd health programs to protect output and meet food safety requirements, sustaining demand for veterinary pharmaceuticals and biologicals.
• Technological advancements in diagnostics and biologicals: Rapid adoption of molecular diagnostics, point-of-care testing, and mRNA vaccine platforms is transforming veterinary care. AI-assisted diagnostic imaging and cloud-connected monitoring devices are enabling faster, more accurate disease detection across both companion and commercial animal settings, pushing the market toward more intelligent, data-driven health management.
United States Animal Health Market Report Segmentation:
The United States Animal Health Market report provides a detailed segmentation analysis to help businesses identify key growth segments and evolving industry dynamics. The market is categorized based on animal type, product type, and region, offering comprehensive insights across the united states animal health market.
Animal Type Insights:
• Commercial: Commercial animals account for the largest share of the market at 61.8% in 2025, reflecting the scale of US cattle, swine, poultry, and aquaculture operations and their ongoing need for disease prevention, growth management, and regulatory-compliant treatment protocols.
• Companion: Companion animals represent the fastest-growing segment, supported by rising pet ownership, increasing humanization of pets, and growing veterinary spending per animal, with premium pharmaceutical, biological, and diagnostic products increasingly concentrated in this category.
Product Type Insights:
• Pharmaceuticals: Pharmaceuticals lead the market at 42.7% in 2025, encompassing antibiotics, antiparasitics, anti-inflammatory drugs, hormones, and anesthetics used across both commercial and companion animal healthcare
• Biologicals, Diagnostics, and Medicinal Feed Additives: Biologicals, including vaccines and emerging immunotherapies, along with diagnostics and medicated feed additives, round out the product landscape, with diagnostics emerging as the fastest-growing category on the back of expanding point-of-care testing adoption.
Regional Insights:
• Midwest: The Midwest leads the market with a 32.5% share in 2025, anchored by a high concentration of cattle feedlots, swine confinement operations, and poultry production infrastructure supported by dense veterinary distribution networks.
• South: The South holds a 30.9% share, supported by large-scale beef cattle and broiler production, a growing companion animal market in urban centers, and expanding aquaculture operations.
• West: The West accounts for 20.1% of the market, driven by concentrated dairy production in California, a strong companion animal market across Pacific urban centers, and rising demand for specialty veterinary services.
• Northeast: The Northeast represents 16.5% of the market, characterized by high companion animal ownership rates, premium veterinary service adoption, and a concentration of specialty and referral veterinary centers.
United States Animal Health Market: Recent News and Developments
March 2026: Zoetis announced that its Vetscan OptiCell platform was named “Best New Companion Animal Product” by S&P Global Animal Health for 2025, reflecting continued innovation in veterinary diagnostics and companion animal care.
June 2026: Merck Animal Health signed a definitive agreement to acquire TARGAN, an animal AgTech company specializing in poultry biodevice technologies, including an automated chick gender-identification system and precision ocular vaccine-spray technology, strengthening its position in poultry health and production.
Challenges Impacting the United States Animal Health Market
High costs associated with advanced veterinary treatments, diagnostics, and specialty pharmaceuticals create access barriers for small-scale producers and rural pet owners, compounded by limited veterinary infrastructure in rural regions.
Stringent regulatory approval pathways administered by the FDA Center for Veterinary Medicine and USDA APHIS extend development timelines and raise compliance costs, creating barriers for new entrants and slowing innovation.
Growing regulatory restrictions on antibiotic use in food animals, driven by antimicrobial resistance concerns, are constraining pharmaceutical revenue in key livestock segments and pushing the industry toward alternative health management products.
Investment Opportunities in the United States Animal Health Market
The united states animal health market presents compelling investment opportunities supported by its projected growth from USD 20.92 Billion in 2025 to USD 47.65 Billion by 2034. mRNA and novel vaccine platforms represent a high-value opportunity as proven human-health technology is adapted for veterinary respiratory and reproductive disease prevention.
Companion animal diagnostics subscription models, combining hardware placement with recurring reagent and software revenue, represent a growing investment frontier. Companies that pair scalable technology with strong veterinary distribution and service networks can build durable competitive positions in this expanding market.
Outlook of the United States Animal Health Market (2026-2034)
The outlook for the united states animal health market is positive, supported by rising pet ownership, an ongoing livestock disease burden, and continuous technological innovation. The market is projected to grow from USD 20.92 Billion in 2025 to USD 47.65 Billion by 2034 at a CAGR of 9.58%, with an anchor value of USD 33.05 Billion expected by 2030.
Continued adoption of AI-assisted diagnostics, expanding mRNA vaccine platforms, and growing companion animal insurance penetration will be the defining trends shaping the united states animal health market through 2034.
Key Players in the United States Animal Health Market
The united states animal health market is served by a mix of global animal health leaders and specialty providers competing on the basis of product portfolio breadth, biologicals innovation, and veterinary distribution reach
• Zoetis Services LLC: The world's largest animal health company, Zoetis offers a broad portfolio of veterinary medicines, vaccines, and diagnostic products spanning companion and commercial animals, with US operations centered in Parsippany, New Jersey, and continued investment in diagnostic innovation.
• Merck & Co. Inc.: A leading provider of veterinary vaccines and pharmaceuticals, Merck Animal Health holds strong positions across companion and livestock health categories and continues to expand its poultry and diagnostic capabilities through targeted acquisitions.
• Elanco: Elanco focuses on companion animal parasiticides and livestock production efficiency products, supported by broad distribution and long-standing veterinary relationships across the United States.
• Boehringer Ingelheim International GmbH: Boehringer Ingelheim maintains a strong presence in both companion animal parasite control and livestock respiratory and reproductive health biologicals, supporting a diversified position across the US market.
Frequently Asked Questions (FAQs): United States Animal Health Market
1. What is the current United States animal health market size?
The United States animal health market reached USD 20.92 Billion in 2025 and is projected to reach USD 47.65 Billion by 2034, growing at a CAGR of 9.58% during 2026-2034.
2. What is animal health?
Animal health refers to the pharmaceuticals, biologicals, diagnostics, and medicated feed additives used to prevent, diagnose, and treat disease across companion and commercial animals, supporting both veterinary clinics and large-scale livestock operations.
3. What are the key drivers of the United States animal health market?
Key drivers include rising pet ownership and companion animal healthcare spending, a growing livestock disease burden, and technological advancements such as mRNA vaccine platforms and AI-assisted diagnostics.
4. Which animal type and product type lead the United States animal health market?
Commercial animals lead by animal type at 61.8% in 2025, reflecting the scale of US livestock operations, while pharmaceuticals lead by product type at 42.7%, driven by broad adoption of antiparasitics, antibiotics, and anti-inflammatory drugs.
5. Who are the key players in the United States animal health market?
Key players in the united states animal health market include Zoetis Services LLC, Merck & Co. Inc., Elanco, and Boehringer Ingelheim International GmbH, among other global animal health providers.
Author IMARC Group
IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: sales@imarcgroup.com,
United States: +1-201971-6302
